Literature DB >> 8757885

Purification and characterization of the staphylococcal slime-associated antigen and its occurrence among Staphylococcus epidermis clinical isolates.

L Baldassarri1, G Donnelli, A Gelosia, M C Voglino, A W Simpson, G D Christensen.   

Abstract

The Staphylococcus epidermidis slime-associated antigen (SAA) was purified and characterized. N-Acetyl-glucosamine accounted for 70% of the dry weight of SAA, which was immunolocalized on the ruthenium red-positive material produced by slime-positive strains. A total of 59% of slime-producing S. epidermidis clinical isolates expressed SAA, while the phenotype slime- SAA+ was never recovered.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8757885      PMCID： PMC174239          DOI： 10.1128/iai.64.8.3410-3415.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  28 in total

1.  Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.

Authors:  D S Davenport; R M Massanari; M A Pfaller; M J Bale; S A Streed; W J Hierholzer
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Hip implant infection. Treatment with resection arthroplasty and late total hip arthroplasty.

Authors:  R H Fitzgerald; D R Jones
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

7.  Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia.

Authors:  M A Ishak; D H Gröschel; G L Mandell; R P Wenzel
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Comparison of microbiologic characteristics of pathogenic and saprophytic coagulase-negative staphylococci from patients on continuous ambulatory peritoneal dialysis.

Authors:  L M Baddour; D L Smalley; A P Kraus; W J Lamoreaux; G D Christensen
Journal:  Diagn Microbiol Infect Dis       Date:  1986-09       Impact factor: 2.803

9.  Aortofemoral graft infection due to Staphylococcus epidermidis.

Authors:  D F Bandyk; G A Berni; B L Thiele; J B Towne
Journal:  Arch Surg       Date:  1984-01

10.  Cell membrane-binding properties of group A streptococcal lipoteichoic acid.

Authors:  I Ofek; E H Beachey; W Jefferson; G L Campbell
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307
View more
  12 in total

Review 1.  Basic aspects of the pathogenesis of staphylococcal polymer-associated infections.

Authors:  C von Eiff; C Heilmann; M Herrmann; G Peters
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 2.  Plastic biliary stent occlusion: factors involved and possible preventive approaches.

Authors:  Gianfranco Donelli; Emilio Guaglianone; Roberta Di Rosa; Fausto Fiocca; Antonio Basoli
Journal:  Clin Med Res       Date:  2007-03

Review 3.  The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Authors:  David Skurnik; Colette Cywes-Bentley; Gerald B Pier
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

4.  The LysM receptor kinase CERK1 mediates bacterial perception in Arabidopsis.

Authors:  Selena Gimenez-Ibanez; Vardis Ntoukakis; John P Rathjen
Journal:  Plant Signal Behav       Date:  2009-06-08

5.  Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics.

Authors:  S Schwank; Z Rajacic; W Zimmerli; J Blaser
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

6.  Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus epidermidis RP62A.

Authors:  Irina Sadovskaya; Evgueny Vinogradov; Sigrid Flahaut; Grigorij Kogan; Saïd Jabbouri
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces.

Authors:  M Hussain; M Herrmann; C von Eiff; F Perdreau-Remington; G Peters
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

8.  Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates.

Authors:  M G Ammendolia; R Di Rosa; L Montanaro; C R Arciola; L Baldassarri
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms.

Authors:  Jeffrey B Kaplan; Kabilan Velliyagounder; Chandran Ragunath; Holger Rohde; Dietrich Mack; Johannes K-M Knobloch; Narayanan Ramasubbu
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

10.  The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin.

Authors:  D McKenney; J Hübner; E Muller; Y Wang; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.